Dexcom CEO Kevin Sayer told investors during his presentation at today’s J.P. Morgan Healthcare Conference that clinical data from the G7 continuous glucose monitoring system exceeded all expectations.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?